Friday, October 30, 2015 7:49:56 AM
Let me set this straight:
You wrote:
- The PACER documents were posted on this board in which Jeannette Bleecker HERSELF explains that she switched the Control and Bavituximab arms.
- A settlement has been made public with CSM paying damages to PPHM.
- A SUMMARY Judgement has been made public forbidding PPHM to pursue the "INTENTIONAL" leg of their claim because they were TO LATE to add it. This forced settlement within the contractual cap/limits of breach of contract. This is a PROCEDURAL based summary judgement and the judge doesn't say anything about the sabotage itself. He just says, not here, not now, not in this trial, you should have filed that earlier.
- Why would CSM even pay 1$ to PPHM if they didn't mess up, let alone hundred of thousands of dollars and legal fees, because also CSM's lawyers don't work for free.
You wrote:
- Except that by the first point it shows this is a false statement because JB confessed about the switching, the documents (PRs) you refer to that would suggest even the BEGINNING of PPHM's involvement in the dose switching ARE NOT EXISTENT.
- Except PPHM no other party has ever written a PR about the dose switching incident. Non of these PRs say what you claim and no others could be found. Pls provide the link supporting your statements.
- This is another misrepresentation. It has been established that JB managed only to pollute the CTRL & 1mg/Kg Bavi ARMS for 25% and the 3mg arm remained untouched. So patients in the Bavi 1mg arm didn't get all there due Bavituximab and those in the Control arm got 25% Bavi they shouldn't have got. In other words that Bavituximab arm scored BETTER then announced because its current results were obtained under a 25% handicap and the control arm under a 25% advantage. Furthermore the 3mg arm was ALSO compared to a control arm that got 25% Bavi which puts the 3mg arm in the disadvantage too. Results of SUNRISE will therefore be BETTER then the PII.
- Bottom line, Bavituximab works MUCH better then announced by PPHM on Sept 7th, 2012 and VERY MUCH better then the conservative salvaged numbers PPHM filed with the FDA which showed only a 70% improvement rather then 113+%. On top of that the combined arms were statistical significant. See also NYAS 2014 Q&A Dr. Brekken on the topic of results being better then those filed.
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.
Recent CDMO News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/12/2024 09:15:31 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of Avid Bioservices, Inc. • PR Newswire (US) • 11/07/2024 10:55:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2024 02:59:47 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2024 02:42:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 02:11:21 AM
- Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction • GlobeNewswire Inc. • 11/06/2024 11:04:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 08:45:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 11:40:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:37:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:22:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:21:22 AM
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM